Management
-
Rainer Lichtenberger, Ph.D. MBA
CEO25 years management in life science Industry, EVP Merckle/ratiopharm group for BD; Since 12 years CEO/COO experience in several SME, raised € 35 Mn venture funds.
-
Christian Wallasch, Ph.D.
COOSeasoned executive management member (COO, CEO) in biopharmaceuticals SME, as Axxima and U3, as well as public companies like Intercell/Valneva. Expert in kinase inhibitors, vaccines development, project management and execution.
-
Sebastian Canisius, MD, Ph.D.
CMOMD with over 10 years experience in clinical development (principal investigator); expert in clinical development of respiratory / infectious diseases.
-
Prof. Oliver Planz, Ph.D.
CSOUniversität D-Tübingen,Co-inventor of the technology, expert in antiviral research und translational preclinical R&D up to clinical studies. Advises the WHO on antiviral strategies against influenza.
-
Henrik Luessen, Ph.D.
CBOSerial entrepreneur/strategic consultant to SME life science companies. Track record of financing/trade sales of € 200 Mn, closing 200 licensing partnerships.
- 1